- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2662-8651
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development of therapeutic antibodies for the treatment of diseases ; volume:3 ; number:1 ; day:22 ; month:11 ; year:2022 ; pages:1-31 ; date:12.2022
Molecular biomedicine ; 3, Heft 1 (22.11.2022), 1-31, 12.2022
- Urheber
-
Wang, Zeng
Wang, Guoqing
Lu, Huaqing
Li, Hongjian
Tang, Mei
Tong, Aiping
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43556-022-00100-4
- URN
-
urn:nbn:de:101:1-2023020409065834026253
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Zeng
- Wang, Guoqing
- Lu, Huaqing
- Li, Hongjian
- Tang, Mei
- Tong, Aiping
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of therapeutic antibodies for the treatment of diseases
Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases
Handbook of therapeutic antibodies, Vol. 3.. Approved therapeutic antibodies
Glycoengineering of Therapeutic Antibodies
Therapeutic antibodies for the prevention and treatment of cancer
Development of therapeutic vaccines for the treatment of diseases
Therapeutic antibodies
Therapeutic antibodies
Targeting MICA with therapeutic antibodies for the treatment of cancer
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
Handbook of therapeutic antibodies, Vol. 2.. Clinical development of antibodies
Handbook of therapeutic antibodies, Vol. 4.. Approved therapeutic antibodies and in vivo diagnostics
Development of therapeutic antibodies for the treatment of diseases
Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases
Handbook of therapeutic antibodies, Vol. 3.. Approved therapeutic antibodies
Glycoengineering of Therapeutic Antibodies
Therapeutic antibodies for the prevention and treatment of cancer
Development of therapeutic vaccines for the treatment of diseases
Therapeutic antibodies
Therapeutic antibodies
Targeting MICA with therapeutic antibodies for the treatment of cancer
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
Handbook of therapeutic antibodies, Vol. 2.. Clinical development of antibodies
Handbook of therapeutic antibodies, Vol. 4.. Approved therapeutic antibodies and in vivo diagnostics
Development of therapeutic antibodies for the treatment of diseases
Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases
Handbook of therapeutic antibodies, Vol. 3.. Approved therapeutic antibodies
Glycoengineering of Therapeutic Antibodies
Therapeutic antibodies for the prevention and treatment of cancer
Development of therapeutic vaccines for the treatment of diseases
Therapeutic antibodies
Therapeutic antibodies
Targeting MICA with therapeutic antibodies for the treatment of cancer
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
Handbook of therapeutic antibodies, Vol. 2.. Clinical development of antibodies